C16G2
Sponsors
Armata Pharmaceuticals, Inc.
Conditions
Dental Caries
Phase 2
Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
CompletedNCT02254993
Start: 2014-10-31End: 2015-07-31Updated: 2019-08-01
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
CompletedNCT02509845
Start: 2015-07-31End: 2016-03-31Updated: 2019-08-01
A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects
CompletedNCT03196219
Start: 2017-07-07End: 2018-01-10Updated: 2022-12-22